Cytopathogenic Effect, Viral
"Cytopathogenic Effect, Viral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Visible morphologic changes in cells infected with viruses. It includes shutdown of cellular RNA and protein synthesis, cell fusion, release of lysosomal enzymes, changes in cell membrane permeability, diffuse changes in intracellular structures, presence of viral inclusion bodies, and chromosomal aberrations. It excludes malignant transformation, which is CELL TRANSFORMATION, VIRAL. Viral cytopathogenic effects provide a valuable method for identifying and classifying the infecting viruses.
MeSH Number(s)
E01.370.225.500.384.235
E05.200.500.384.235
E05.242.384.235
G06.920.190
Concept/Terms
Cytopathogenic Effect, Viral- Cytopathogenic Effect, Viral
- Cytopathic Effect, Viral
- Cytopathic Effects, Viral
- Effect, Viral Cytopathic
- Effects, Viral Cytopathic
- Viral Cytopathic Effect
- Viral Cytopathic Effects
- Viral Cytopathogenic Effect
- Cytopathogenic Effects, Viral
- Effect, Viral Cytopathogenic
- Effects, Viral Cytopathogenic
- Viral Cytopathogenic Effects
Below are MeSH descriptors whose meaning is more general than "Cytopathogenic Effect, Viral".
Below are MeSH descriptors whose meaning is more specific than "Cytopathogenic Effect, Viral".
This graph shows the total number of publications written about "Cytopathogenic Effect, Viral" by people in Harvard Catalyst Profiles by year, and whether "Cytopathogenic Effect, Viral" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 9 | 9 |
| 1995 | 0 | 2 | 2 |
| 1996 | 0 | 5 | 5 |
| 1997 | 0 | 4 | 4 |
| 1998 | 0 | 7 | 7 |
| 1999 | 0 | 4 | 4 |
| 2000 | 0 | 3 | 3 |
| 2001 | 0 | 7 | 7 |
| 2002 | 1 | 3 | 4 |
| 2003 | 0 | 2 | 2 |
| 2004 | 0 | 3 | 3 |
| 2005 | 1 | 0 | 1 |
| 2006 | 0 | 3 | 3 |
| 2007 | 0 | 3 | 3 |
| 2008 | 0 | 3 | 3 |
| 2009 | 0 | 2 | 2 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2012 | 0 | 4 | 4 |
| 2013 | 0 | 1 | 1 |
| 2017 | 0 | 2 | 2 |
| 2019 | 0 | 1 | 1 |
| 2021 | 0 | 2 | 2 |
Below are the most recent publications written about "Cytopathogenic Effect, Viral" by people in Profiles.
-
Immunostimulatory bacterial antigen-armed oncolytic measles virotherapy significantly increases the potency of anti-PD1 checkpoint therapy. J Clin Invest. 2021 07 01; 131(13).
-
The synthetic opioid fentanyl enhances viral replication in vitro. PLoS One. 2021; 16(4):e0249581.
-
SARS-CoV-2 hijacks folate and one-carbon metabolism for viral replication. Nat Commun. 2021 03 15; 12(1):1676.
-
Human Tibroviruses: Commensals or Lethal Pathogens? Viruses. 2020 02 25; 12(3).
-
Atlastin Endoplasmic Reticulum-Shaping Proteins Facilitate Zika Virus Replication. J Virol. 2019 12 01; 93(23).
-
Zika virus replication and cytopathic effects in liver cells. PLoS One. 2019; 14(3):e0214016.
-
Ebola virus disease and pregnancy: A review of the current knowledge of Ebola virus pathogenesis, maternal, and neonatal outcomes. Birth Defects Res. 2017 Mar 15; 109(5):353-362.
-
Human Gut-On-A-Chip Supports Polarized Infection of Coxsackie B1 Virus In Vitro. PLoS One. 2017; 12(2):e0169412.
-
Combination therapy of oncolytic herpes simplex virus HF10 and bevacizumab against experimental model of human breast carcinoma xenograft. Int J Cancer. 2015 Apr 01; 136(7):1718-30.
-
Sulfonyl-polyol N,N-dichloroamines with rapid, broad-spectrum antimicrobial activity. Bioorg Med Chem Lett. 2013 Oct 15; 23(20):5650-3.